News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
703,217 Results
Type
Article (59247)
Company Profile (96)
Press Release (643874)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (191050)
Career Advice (2965)
Deals (35452)
Drug Delivery (111)
Drug Development (82078)
Employer Resources (167)
FDA (15899)
Job Trends (15091)
News (333551)
Policy (32963)
Tag
Academia (2771)
Academic (2)
Accelerated approval (6)
Adcomms (26)
Allergies (92)
Alliances (46907)
ALS (98)
Alzheimer's disease (1430)
Antibody-drug conjugate (ADC) (132)
Approvals (15887)
Artificial intelligence (280)
Autoimmune disease (26)
Automation (16)
Bankruptcy (334)
Best Places to Work (11877)
BIOSECURE Act (21)
Biosimilars (108)
Biotechnology (65)
Bladder cancer (82)
Brain cancer (29)
Breast cancer (295)
Cancer (2336)
Cardiovascular disease (183)
Career advice (2511)
Career pathing (33)
CAR-T (163)
Cell therapy (459)
Cervical cancer (21)
Clinical research (66611)
Collaboration (859)
Company closure (1)
Compensation (460)
Complete response letters (29)
COVID-19 (2686)
CRISPR (48)
C-suite (273)
Cystic fibrosis (105)
Data (2299)
Decentralized trials (2)
Denatured (29)
Depression (46)
Diabetes (281)
Diagnostics (6568)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (125)
Drug pricing (112)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (72571)
Editorial (45)
Employer branding (20)
Employer resources (147)
Events (111048)
Executive appointments (774)
FDA (17257)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (784)
Gene editing (119)
Generative AI (22)
Gene therapy (330)
GLP-1 (748)
Government (4872)
Grass and pollen (6)
Guidances (107)
Healthcare (19760)
Huntington's disease (19)
IgA nephropathy (27)
Immunology and inflammation (131)
Indications (30)
Infectious disease (2837)
Inflammatory bowel disease (149)
Inflation Reduction Act (9)
Influenza (56)
Intellectual property (101)
Interviews (562)
IPO (16701)
IRA (45)
Job creations (3642)
Job search strategy (2100)
Kidney cancer (11)
Labor market (32)
Layoffs (526)
Leadership (24)
Legal (7756)
Liver cancer (75)
Lung cancer (323)
Lymphoma (155)
Machine learning (8)
Management (59)
Manufacturing (321)
MASH (70)
Medical device (13802)
Medtech (13807)
Mergers & acquisitions (19364)
Metabolic disorders (707)
Multiple sclerosis (86)
NASH (15)
Neurodegenerative disease (99)
Neuropsychiatric disorders (28)
Neuroscience (1999)
NextGen: Class of 2025 (6849)
Non-profit (4785)
Now hiring (11)
Obesity (376)
Opinion (243)
Ovarian cancer (76)
Pain (100)
Pancreatic cancer (90)
Parkinson's disease (153)
Partnered (21)
Patents (246)
Patient recruitment (118)
Peanut (50)
People (60500)
Pharmaceutical (27)
Pharmacy benefit managers (18)
Phase I (20714)
Phase II (29295)
Phase III (21770)
Pipeline (1286)
Policy (161)
Postmarket research (2732)
Preclinical (9026)
Press Release (63)
Prostate cancer (112)
Psychedelics (34)
Radiopharmaceuticals (265)
Rare diseases (391)
Real estate (6170)
Recruiting (65)
Regulatory (22585)
Reports (36)
Research institute (2446)
Resumes & cover letters (457)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (75)
Series A (137)
Series B (89)
Service/supplier (9)
Sickle cell disease (55)
Special edition (14)
Spinal muscular atrophy (152)
Sponsored (31)
Startups (3427)
State (1)
Stomach cancer (12)
Supply chain (66)
Tariffs (41)
The Weekly (47)
Vaccines (738)
Venture capitalists (41)
Weight loss (242)
Women's health (34)
Worklife (19)
Date
Today (299)
Last 7 days (867)
Last 30 days (2969)
Last 365 days (32931)
2025 (11558)
2024 (35342)
2023 (40136)
2022 (51211)
2021 (56258)
2020 (55092)
2019 (48565)
2018 (36840)
2017 (33212)
2016 (32649)
2015 (38303)
2014 (31014)
2013 (26782)
2012 (28353)
2011 (28825)
2010 (27288)
Location
Africa (941)
Alabama (56)
Alaska (7)
Arizona (193)
Arkansas (14)
Asia (40721)
Australia (7209)
California (6147)
Canada (2041)
China (538)
Colorado (268)
Connecticut (284)
Delaware (153)
Europe (94696)
Florida (928)
Georgia (217)
Idaho (61)
Illinois (578)
India (26)
Indiana (317)
Iowa (9)
Japan (166)
Kansas (104)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (928)
Massachusetts (4526)
Michigan (238)
Minnesota (407)
Mississippi (2)
Missouri (90)
Montana (30)
Nebraska (23)
Nevada (65)
New Hampshire (70)
New Jersey (1766)
New Mexico (31)
New York (1780)
North Carolina (1044)
North Dakota (8)
Northern California (2706)
Ohio (210)
Oklahoma (15)
Oregon (36)
Pennsylvania (1359)
Puerto Rico (11)
Rhode Island (30)
South America (1329)
South Carolina (26)
South Dakota (1)
Southern California (2330)
Tennessee (103)
Texas (931)
United States (23470)
Utah (185)
Virginia (156)
Washington D.C. (60)
Washington State (558)
West Virginia (3)
Wisconsin (61)
703,217 Results for "public relations society of america prsa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mitsubishi Tanabe Pharma America Announces Publication of Preclinical Research on the Role of Edaravone in Mitigating TDP-43 Mislocalization in ALS
March 26, 2025
·
4 min read
Press Releases
Mitsubishi Tanabe Pharma America Announces Presentations at the 30th World Congress on Parkinson’s Disease and Related Disorders (IAPRD)
May 7, 2025
·
3 min read
Press Releases
Phio Pharmaceuticals Announces Publication in Frontiers in Immunology
Journal is the official publication of the International Union of Immunological Societies
December 12, 2024
·
4 min read
Press Releases
Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering
May 6, 2025
·
4 min read
Press Releases
Palatin Technologies Announces Pricing of up to $23 Million Public Offering
May 7, 2025
·
5 min read
Press Releases
Theriva Biologics Announces Pricing of $7.5 Million Public Offering
May 7, 2025
·
5 min read
Press Releases
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
April 28, 2025
·
7 min read
Press Releases
BD to Present at Bank of America Securities Health Care Conference
May 1, 2025
·
1 min read
Deals
Unusual New Fund Launches to Unlock Some $30B of Capital ‘Trapped’ in Public Biotechs
Alis Biosciences’ plan is a familiar tactic in the private equity world, but the firm will instead be listed on the public markets “in due course.”
April 18, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering
April 14, 2025
·
5 min read
1 of 70,322
Next
